Australian Womens Health Market Expected to Grow Faster According to New Research Report 2023-2028

Report Overview

The Australian Womens Health market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

In 2018, just over half of Australias population51% or 12.6 million peoplewere female. On average, Australian females experience different health outcomes than Australian males. Compared with males, females have a higher life expectancy and experienced more of their total disease burden due to living with the disease rather than from dying early from disease and injury. Womens health includes all of the therapeutics, drugs, and surgical offerings precautionary measures for the various disorders associated with the women population. These disorders vary from nutrition, oncology, reproductive, menopause, urological as well as other Health applications. Womens health is focused on providing better management of diseases and improving the overall health of the women population.

Market Drivers

The increasing prevalence of preventing women-related health disorders by the population and authorities is expected to promote the market value. The rise in the levels of research & development initiatives undertaken by various manufacturers in providing better health services for women is expected to positively affect the growth of the market as well. Lack of qualitative Health services for women from the under-developed regions of the world is expected to provide better areas for growth of the market value. Changes in the lifestyle of individuals coupled with bad nutritional intake are factors driving the growth of the market.

Major Womens Health Disease Indication

The leading cause of death for females in 2017 was Dementia and Alzheimer disease. Fewer than 1 in 10 women ate the recommended amount of fruit and vegetables in 201718. The leading cause of total disease burden for females in 2015 was coronary heart disease. In 2015, females experienced a smaller share of the total disease burden (47%) than males (53%). A larger proportion of the total disease burden for females was caused by living with the disease. For males, the greatest proportion of total burden was caused by premature death.

The distribution of overall burden between the sexes varied by disease group. Compared with males, females experience a greater proportion of the total burden from:

blood and metabolic disorders (59%)
neurological conditions (58%)
musculoskeletal conditions (55%)

Nearly half (44%) of the total burden of disease for females is from cancer, musculoskeletal conditions, and cardiovascular disease.

Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/139954/

Major Players

Some of the major players in the Australian Women's Health are Allergan; Bayer AG; Merck & Co., Inc.; Pfizer; Teva Pharmaceuticals; Agile Therapeutics; Amgen, Inc.; AstraZeneca; Bristol-Myers Squibb; and Ferring B.V. Collaborations for product development, expansion of product portfolios, and regional expansion in emerging markets are the key strategic undertakings of these companies to increase their market share.

The Australian Womens Health Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Australian Womens Health market. This report explores all the key factors affecting the growth of the global Australian Womens Health market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

To Know More About COVID-19 Impact On Australian Womens Health Market @ https://www.prudentmarkets.com/sample-request/139954/

Market Segmentation

By Application:

By application, contraceptives accounted for the largest market share of the women's health market in 2019 Contraceptives dominated the market with a share of over 43.0% in 2019 in terms of revenue. The use of female contraception is beneficial in the prevention of health issues associated with pregnancy, particularly for pubescent girls, as well as in pregnancy planning to reduce the chances of infant mortality, which is higher in childbirths separated by a lesser number of years. Besides, it provides various other prospective benefits comprising prolonged prospects for education and women empowerment, along with maintaining a healthy population and economic growth of nations.

Postmenopausal osteoporosis held the second-largest market share in 2019, owing to the concern associated with decreasing bone density and an increase in chances of having fractures followed by Hormonal infertility, Menopause, Endometriosis, PCOS, and others.

By Services:

Based on services, the market is segmented into Medicare services, Primary health care, Private health insurance, & Hospital care. In 2018-19, Australia's females claimed more than 245 million services through Medicare and received an average of 19.5 Medicare services per person in that year. Based on the ABS Patient Experiences Survey, in 2018-19, 88% of females aged 15 and over were estimated to have visited their general practitioner (GP) in the last 12 months. 9 in 10 Australian females visited a general practitioner in the previous 12 months. Based on the 2017-18 ABS Patient Experience Survey, more than half of Australian females (57%) had some form of private health insurance. In 2017-18, there were 3.9 million emergency department presentations among Australian females, accounting for 50% of all presentations. Among adult females, rates of emergency department presentations were highest in those aged 75-84 and 85 years and older (524 and 750 per 1,000 populations respectively).

Major Players

Some of the major players in the Australian Women's Health are Allergan; Bayer AG; Merck & Co., Inc.; Pfizer; Teva Pharmaceuticals; Agile Therapeutics; Amgen, Inc.; AstraZeneca; Bristol-Myers Squibb; and Ferring B.V. Collaborations for product development, expansion of product portfolios, and regional expansion in emerging markets are the key strategic undertakings of these companies to increase their market share.

Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/139954/

The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global Australian Womens Health Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.

Strategic Points Covered in Table of Content of Global Australian Womens Health Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Australian Womens Health market
Chapter 2: Exclusive Summary - the basic information of the Australian Womens Health Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Australian Womens Health
Chapter 4: Presenting the Australian Womens Health Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the Australian Womens Health market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Any Questions? Feel Free To Enquire Here. We Will put you on the Right Path @ https://www.prudentmarkets.com/enquiry-request/139954/

Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.

Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.

Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.

In conclusion, the Australian Womens Health Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.